Can-Do Core Lab
ONCOLOGY IMAGING SERVICES FOR CLINICAL TRIALS
The pipeline of potential cancer treatments continues to expand, resulting in an increasing number of clinical trials utilizing imaging. Whether a trial is assessing the longest diameter, sum of the products of diameters (SPD), tumor volume, or other oncology endpoints – BioTel Research analyzes imaging data and delivers structural and volumetric measures for a variety of oncology/hematology assessment criteria across imaging modalities.
Our Medical, Scientific, and Operations experts help emerging and established pharmaceutical and biotech companies accelerate the advancement of their compounds through clinical testing and on to FDA approval efficiently.
Full-Service Oncology Model - Full Spectrum of Modalities
• Study design consulting, protocol and assessment criteria guidance
• Integrated technologies that enable imaging visualization, analysis, tracking, and reporting
• End-to-end support from a dedicated project team with in-depth oncology experience
Process Management
• Standardized MR/PET/CT image acquisition protocols
• Imaging Review Charter
• Dedicated Project Management
Oncology Imaging
• Positron Emission Tomography (PET)
• Computed Tomography (CT)
• Magnetic Resonance Imaging (MRI)
• Dynamic Contrast-Enhanced (DCE)
• Diffusion Weighted (DW)
• Photography
• Bone Scan
• X-Ray
Oncology Response Criteria
• iRECIST
• LYRIC
• RECIST 1.1
• RANO
• Lugano
• PCWG3
• mRECIST (HCC)
• EORTC (FDG-PET)
Quality Assurance
• SOP-driven processes
• Part 11 – FDA compliant
• Dedicated imaging quality assurance...
More Info Less Info